| Title |
Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial
|
|---|---|
| Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 2013
|
| DOI | 10.2147/dmso.s48858 |
| Pubmed ID | |
| Authors |
Daniel Cuevas-Ramos, Paloma Almeda-Valdés, Emma Chávez-Manzanera, Clara Elena Meza-Arana, Griselda Brito-Córdova, Roopa Mehta, Oscar Pérez-Méndez, Francisco J Gómez-Pérez |
| Abstract |
Epidemiologic evidence suggests that tomato-based products could reduce the risk of cardiovascular diseases. One of the main cardiovascular risk factors is low levels of high-density lipoprotein cholesterol (HDL-C). This study aimed to prospectively evaluate the effect of tomato consumption on HDL-C levels. |
X Demographics
The data shown below were collected from the profiles of 72 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 6 | 8% |
| United States | 4 | 6% |
| Saudi Arabia | 2 | 3% |
| El Salvador | 1 | 1% |
| Dominican Republic | 1 | 1% |
| Argentina | 1 | 1% |
| Oman | 1 | 1% |
| Mexico | 1 | 1% |
| Iraq | 1 | 1% |
| Other | 2 | 3% |
| Unknown | 52 | 72% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 65 | 90% |
| Practitioners (doctors, other healthcare professionals) | 4 | 6% |
| Scientists | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 1% |
| Spain | 1 | 1% |
| Unknown | 86 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 16% |
| Student > Bachelor | 13 | 15% |
| Student > Master | 9 | 10% |
| Student > Ph. D. Student | 8 | 9% |
| Professor | 5 | 6% |
| Other | 11 | 13% |
| Unknown | 28 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 31% |
| Agricultural and Biological Sciences | 12 | 14% |
| Nursing and Health Professions | 4 | 5% |
| Biochemistry, Genetics and Molecular Biology | 4 | 5% |
| Chemistry | 3 | 3% |
| Other | 5 | 6% |
| Unknown | 33 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 85. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2022.
All research outputs
#501,510
of 25,457,858 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#26
of 1,184 outputs
Outputs of similar age
#3,599
of 206,924 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1
of 10 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them